| Vincent Barnhart, MD | |
|
2 Keefer Dr, Mercersburg, PA 17236-1732 | |
| (717) 263-9555 | |
| (717) 328-0071 |
| Full Name | Vincent Barnhart |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 2 Keefer Dr, Mercersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588748941 | NPI | - | NPPES |
| 14037199 | Other | CAQH | |
| 103322280 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD064427L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Home Health Care, Inc | Chambersburg, PA | Home health agency |
| Wellspan Vna Home Care | York, PA | Home health agency |
| Team Home Health | Mcconnellsburg, PA | Home health agency |
| Heartland Hospice Services, Inc | York, PA | Hospice |
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Waynesboro Hospital | Waynesboro, PA | Hospital |
| Fulton County Medical Center | Mcconnellsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
| Summit Physician Services | 5496659484 | 353 |
News Archive
American CareSource Holdings Inc. today reported fourth quarter 2009 net income of $1.4 million or $0.07 per diluted share, compared to net income of $1.5 million, or $.08 per diluted share reported 2008.
Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.
The Clinton Foundation's HIV/AIDS Initiative has trained 10 HIV-positive people in Lesotho to help doctors, nurses and pharmacists cope with treating people with HIV/AIDS in a country with a severe shortage of health workers, South Africa's Independent Online reports.
Bristol-Myers Squibb today announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. The new BARACLUDE data were presented today at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.
› Verified 3 days ago
| Entity Name | Summit Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306840814 PECOS PAC ID: 5496659484 Enrollment ID: O20031121000259 |
News Archive
American CareSource Holdings Inc. today reported fourth quarter 2009 net income of $1.4 million or $0.07 per diluted share, compared to net income of $1.5 million, or $.08 per diluted share reported 2008.
Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.
The Clinton Foundation's HIV/AIDS Initiative has trained 10 HIV-positive people in Lesotho to help doctors, nurses and pharmacists cope with treating people with HIV/AIDS in a country with a severe shortage of health workers, South Africa's Independent Online reports.
Bristol-Myers Squibb today announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. The new BARACLUDE data were presented today at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.
› Verified 3 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
American CareSource Holdings Inc. today reported fourth quarter 2009 net income of $1.4 million or $0.07 per diluted share, compared to net income of $1.5 million, or $.08 per diluted share reported 2008.
Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.
The Clinton Foundation's HIV/AIDS Initiative has trained 10 HIV-positive people in Lesotho to help doctors, nurses and pharmacists cope with treating people with HIV/AIDS in a country with a severe shortage of health workers, South Africa's Independent Online reports.
Bristol-Myers Squibb today announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. The new BARACLUDE data were presented today at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vincent Barnhart, MD 601 Memory Ln, York, PA 17402-2231 Ph: (717) 851-1405 | Vincent Barnhart, MD 2 Keefer Dr, Mercersburg, PA 17236-1732 Ph: (717) 263-9555 |
News Archive
American CareSource Holdings Inc. today reported fourth quarter 2009 net income of $1.4 million or $0.07 per diluted share, compared to net income of $1.5 million, or $.08 per diluted share reported 2008.
Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.
The Clinton Foundation's HIV/AIDS Initiative has trained 10 HIV-positive people in Lesotho to help doctors, nurses and pharmacists cope with treating people with HIV/AIDS in a country with a severe shortage of health workers, South Africa's Independent Online reports.
Bristol-Myers Squibb today announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. The new BARACLUDE data were presented today at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.
› Verified 3 days ago
Robert B. George, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Keefer Dr, Mercersburg, PA 17236 Phone: 717-328-2119 Fax: 717-328-0071 | |
Dr. Elizabeth Ann George, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Keefer Drive, Mercersburg Health Center, Mercersburg, PA 17236 Phone: 717-328-2115 Fax: 717-328-4322 | |
Joanna M Brady, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Keefer Dr, Mercersburg, PA 17236 Phone: 717-328-2119 Fax: 717-328-0071 |